Stuart Maddin
- Dermatology top 2%
- Acne and Rosacea Treatments and Effects 9
- Dermatology and Skin Diseases 5
- Skin Protection and Aging 3
- Medicine and Dermatology Studies History 2
-
- Nail Diseases and Treatments 3
-
- Urticaria and Related Conditions 4
-
- Drug-Induced Adverse Reactions 3
-
- Psoriasis: Treatment and Pathogenesis 3
- Co-authors
- P AgacheLara J. BurrowsJ. LauharantaM. ZultakJerry ShapiroJohn QuiringNorman B. KanofJason K. Rivers
- Cited by
- DermatologyCell BiologyEpidemiology
- Journals
- Journal of the American Academy of Dermatology (5 papers)JAMA (3 papers)Plastic & Reconstructive Surgery (2 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Stuart Maddin
27 papers receiving 306 citations
Peers
Comparison fields: 5 of 77
- Dermatology 251
- Cell Biology 83
- Epidemiology 89
- Urology 14
- Immunology and Allergy 12
Countries citing papers authored by Stuart Maddin
This map shows the geographic impact of Stuart Maddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Maddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Maddin more than expected).
Fields of papers citing papers by Stuart Maddin
This network shows the impact of papers produced by Stuart Maddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Maddin. The network helps show where Stuart Maddin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stuart Maddin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized, placebo-controlled, phase 3 study of itraconazole for the treatment of onychomycosis. | 2013 | 14 |
| 2 | Systemic and Light Therapies for the Management of Childhood Psoriasis: Part II | 2008 | 7 |
| 3 | 2006 | 48 | |
| 4 | Pimecrolimus and tacrolimus: the US FDA public health advisory. | 2005 | 2 |
| 5 | 2000 | 49 | |
| 6 | 2000 | 17 | |
| 7 | 1999 | 81 | |
| 8 | 1998 | 6 | |
| 9 | 1996 | 12 | |
| 10 | 1993 | 1 | |
| 11 | 1993 | 2 | |
| 12 | 1993 | 11 | |
| 13 | 1982 | 8 | |
| 14 | 1977 | 6 | |
| 15 | Synopsis of dermatology | 1970 | 4 |
| 16 | 1969 | 2 | |
| 17 | 1969 | 1 | |
| 18 | Therapeutic Agents in Acne Vulgaris: Part II. D-Alpha Amino Benzyl Penicillin, Erythromycin and Sulfadimethoxine. | 1965 | 2 |
| 19 | THERAPEUTIC AGENTS IN ACNE VULGARIS. I. TETRACYCLINE. | 1963 | 12 |
| 20 | 1951 | 0 |
About Stuart Maddin
Stuart Maddin is a scholar working on Dermatology, Rheumatology, Urology, Toxicology and Small Animals, having authored 30 papers that have together received 346 indexed citations. Recurring topics across this work include Acne and Rosacea Treatments and Effects (9 papers), Dermatology and Skin Diseases (5 papers), Urticaria and Related Conditions (4 papers), Nail Diseases and Treatments (3 papers), Drug-Induced Adverse Reactions (3 papers), Skin Protection and Aging (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers) and Medicine and Dermatology Studies History (2 papers). The work is most often cited by research in Dermatology (251 citations), Cell Biology (83 citations), Epidemiology (89 citations), Urology (14 citations) and Immunology and Allergy (12 citations). Stuart Maddin has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include P Agache, Lara J. Burrows, J. Lauharanta, M. Zultak, Jerry Shapiro, John Quiring, Norman B. Kanof, Jason K. Rivers, Yves Poulin and David C. Wilson. Their work appears in journals such as Journal of the American Academy of Dermatology, JAMA, Plastic & Reconstructive Surgery, Journal of Dermatological Treatment and Journal of Cutaneous Medicine and Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.